✦ LIBER ✦

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

✍ Scribed by Matucci-Cerinic, M.; Denton, C. P.; Furst, D. E.; Mayes, M. D.; Hsu, V. M.; Carpentier, P.; Wigley, F. M.; Black, C. M.; Fessler, B. J.; Merkel, P. A.; Pope, J. E.; Sweiss, N. J.; Doyle, M. K.; Hellmich, B.; Medsger, T. A.; Morganti, A.; Kramer, F.; Korn, J. H.; Seibold, J. R.

Book ID: 125512014
Publisher: BMJ Publishing Group
Year: 2010
Tongue: English
Weight: 241 KB
Volume: 70
Category: Article
ISSN: 0003-4967
DOI: 10.1136/ard.2010.130658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christi 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Daclizumab, a humanised monoclonal antib

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

✍ Van Assche, G; Sandborn, W J; Feagan, B G; Salzberg, B A; Silvers, D; Monroe, P 📂 Article 📅 2006 🏛 BMJ Publishing Group 🌐 English ⚖ 1010 KB

Impact of ustekinumab on health-related

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB